Boston Scientific Corporation (BSX) Soars to 52-Week High, Time to Cash Out?

Zacks09-20

Have you been paying attention to shares of Boston Scientific (BSX)? Shares have been on the move with the stock up 5.2% over the past month. The stock hit a new 52-week high of $84.89 in the previous...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2468627701?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7h8ntzJXcDOdVmDKQ08gRg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a","is_english":true,"pubTime":"2024-09-20 21:15","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2468627701","market":"us","top_or_hot":-1,"title":"Boston Scientific Corporation (BSX) Soars to 52-Week High, Time to Cash Out?","media":"Zacks","content":"<div>\n<p>Have you been paying attention to shares of Boston Scientific (BSX)? Shares have been on the move with the stock up 5.2% over the past month. The stock hit a new 52-week high of $84.89 in the previous...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-corporation-bsx-soars-131505169.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boston Scientific Corporation (BSX) Soars to 52-Week High, Time to Cash Out?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoston Scientific Corporation (BSX) Soars to 52-Week High, Time to Cash Out?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-20 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/boston-scientific-corporation-bsx-soars-131505169.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Have you been paying attention to shares of Boston Scientific (BSX)? Shares have been on the move with the stock up 5.2% over the past month. The stock hit a new 52-week high of $84.89 in the previous...</p>\n\n<a href=\"https://finance.yahoo.com/news/boston-scientific-corporation-bsx-soars-131505169.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0187121727.USD","symbol_name":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","start_time":0,"source_url":"https://finance.yahoo.com/news/boston-scientific-corporation-bsx-soars-131505169.html","article_id":"2468627701","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7h8ntzJXcDOdVmDKQ08gRg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e8e4b0344809eaac6d73c9fd25fd180a"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468627701","pubTimestamp":1726838105,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Have you been paying attention to shares of Boston Scientific ?Shares have been on the move with the stock up 5.2% over the past month. The stock hit a new 52-week high of $84.89 in the previous session. Boston Scientific has gained 44.8% since the start of the year compared to the 11.6% move for the Zacks Medical sector and the 15.8% return for the Zacks Medical - Products industry.The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on July 24, 2024, Boston Scientific reported EPS of $0.62 versus consensus estimate of $0.58 while it beat the consensus revenue estimate by 2.51%.For the current fiscal year, Boston Scientific is expected to post earnings of $2.40 per share on $16.26 billion in revenues. This represents a 17.07% change in EPS on a 14.18% change in revenues. For the next fiscal year, the company is expected to earn $2.71 per share on $17.95 billi","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","LU0238689110.USD":"贝莱德环球动力股票基金","BK4585":"ETF&股票定投概念","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","BK4567":"ESG概念","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","BSX":"波士顿科学","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1153585028.USD":"BGF GLOBAL LONG-HORIZON EQUITY  \"A4\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","BK4082":"医疗保健设备","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","BK4588":"碎股","LU0353189763.USD":"ALLSPRING  US ALL CAP GROWTH FUND \"I\" (USD) ACC","LU0823417653.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) ACC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","BK4581":"高盛持仓","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","BK4504":"桥水持仓","LU0122379950.USD":"贝莱德世界健康科学A2","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU0345769631.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) INC","LU1718418525.SGD":"JPMorgan Investment Funds - Global Select Equity A (acc) SGD","LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","LU2506952097.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU0077335932.USD":"FIDELITY AMERICAN GROWTH \"A\" INC","PETQ":"Petiq Inc.","LU2506951958.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","BK4175":"保健护理产品经销商","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC"},"translate_title":"波士顿科学公司(BSX)飙升至52周高点，是时候套现了吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PETQ":1,"BSX":1},"content_text":"Have you been paying attention to shares of Boston Scientific (BSX)? Shares have been on the move with the stock up 5.2% over the past month. The stock hit a new 52-week high of $84.89 in the previous session. Boston Scientific has gained 44.8% since the start of the year compared to the 11.6% move for the Zacks Medical sector and the 15.8% return for the Zacks Medical - Products industry.\nWhat's Driving the Outperformance?\nThe stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on July 24, 2024, Boston Scientific reported EPS of $0.62 versus consensus estimate of $0.58 while it beat the consensus revenue estimate by 2.51%.\nFor the current fiscal year, Boston Scientific is expected to post earnings of $2.40 per share on $16.26 billion in revenues. This represents a 17.07% change in EPS on a 14.18% change in revenues. For the next fiscal year, the company is expected to earn $2.71 per share on $17.95 billion in revenues. This represents a year-over-year change of 13.03% and 10.41%, respectively.\nValuation Metrics\nBoston Scientific may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.\nOn this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. Investors should consider the style scores a valuable tool that can help you to pick the most appropriate Zacks Rank stocks based on their individual investment style.\nBoston Scientific has a Value Score of C. The stock's Growth and Momentum Scores are B and A, respectively, giving the company a VGM Score of B.\nIn terms of its value breakdown, the stock currently trades at 34.9X current fiscal year EPS estimates, which is a premium to the peer industry average of 24.2X. On a trailing cash flow basis, the stock currently trades at 28.8X versus its peer group's average of 12.1X. Additionally, the stock has a PEG ratio of 2.77. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.\nZacks Rank\nWe also need to look at the Zacks Rank for the stock, as this supersedes any trend on the style score front. Fortunately, Boston Scientific currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.\nSince we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Boston Scientific meets the list of requirements. Thus, it seems as though Boston Scientific shares could have potential in the weeks and months to come.\nHow Does BSX Stack Up to the Competition?\nShares of BSX have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is PetIQ, Inc. (PETQ). PETQ has a Zacks Rank of # 2 (Buy) and a Value Score of A, a Growth Score of A, and a Momentum Score of B.\nEarnings were strong last quarter. PetIQ, Inc. beat our consensus estimate by 42.86%, and for the current fiscal year, PETQ is expected to post earnings of $1.44 per share on revenue of $1.15 billion.\nShares of PetIQ, Inc. have gained 0.9% over the past month, and currently trade at a forward P/E of 21.36X and a P/CF of 11.46X.\nThe Medical - Products industry is in the top 27% of all the industries we have in our universe, so it looks like there are some nice tailwinds for BSX and PETQ, even beyond their own solid fundamental situation.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nBoston Scientific Corporation (BSX) : Free Stock Analysis Report\nPetIQ, Inc. (PETQ) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468627701"}